Bicara Therapeutics Inc. (BCAX)
Pharmaceutical Preparations
Latest Price
$23.20
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
6.90
P/B Ratio
3.36
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7.26M | $215.0M | 11.01% | -- | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 6.34M | $188.0M | 9.61% | -267.3K | 2026-06-30 |
| Siren, L.L.C. | 5.60M | $166.0M | 8.50% | -200.0K | 2026-06-30 |
| Vestal Point Capital, LP | 5.25M | $155.0M | 7.96% | -175.0K | 2026-06-30 |
| Deep Track Capital, LP | 4.10M | $121.0M | 6.22% | +37.5K | 2026-06-30 |
| BlackRock, Inc. | 3.85M | $114.0M | 5.84% | +1.00M | 2026-06-30 |
| Jupiter Topco LLC | 3.17M | $93.0M | 4.81% | -- | 2026-06-30 |
| RED TREE MANAGEMENT, LLC | 3.16M | $93.0M | 4.80% | -7.0K | 2026-06-30 |
| TPG GP A, LLC | 3.01M | $89.0M | 4.57% | -- | 2026-06-30 |
| Royalty Pharma Sub-Manager, LLC | 2.39M | $60.0M | 3.62% | -- | 2026-06-30 |